CSIMarket
Cara Therapeutics inc   (CARA)
Other Ticker:  
 
 

Cara Therapeutics Inc 's Yearly Capital Expenditures Growth 5 Years

 

Select the Comparisons : Select the Ratio:



CARA Annual Capital Expenditures Growth

2023
2022
2020
2019
2018
Y / Y Annual Capital Expenditures Change 5423.26 % -87.68 % 1838.89 % -75.34 % 25.86 %
Annual Capital Expenditures (in millions $) $2.38 $0.04 $0.35 $0.02 $0.07


Annual Capital Expenditures Growth Comment
Cara Therapeutics Inc 's Annual Capital Expenditures for the fiscal year ended 2023, more than doubled to 5423.26% to $2.38 millions, from $0.04 millions achieved a year ago. Cara Therapeutics Inc 's growrh rate for Capital Expenditures improved from -87.68 % decline in the fiscal year 2022.

Cara Therapeutics Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Capital Expenditures within Healthcare SectorY/Y Capital Expenditures Growth %2023 Annual Capital Expenditures
Guardant Health Inc -73.55 %$ 20.486  millions
Vir Biotechnology Inc -68.29 %$ 21.573  millions
Xencor Inc -51.04 %$ 21.251  millions
Innovage Holding Corp -38.92 %$ 23.354  millions
Recursion Pharmaceuticals Inc -66.40 %$ 12.552  millions
Valneva Se -51.34 %$ 15.939  millions
Glaukos Corp -33.10 %$ 20.248  millions
Adaptimmune Therapeutics Plc -83.59 %$ 4.880  millions
Zai Lab Limited -66.01 %$ 8.491  millions
Conmed Corporation -12.64 %$ 19.032  millions
Iovance Biotherapeutics Inc   9.13 %$ 22.290  millions
Avanos Medical Inc -7.77 %$ 17.800  millions
Butterfly Network inc -68.40 %$ 5.783  millions
Denali Therapeutics Inc -27.44 %$ 12.939  millions
Roivant Sciences Ltd -27.22 %$ 12.690  millions
The Beauty Health Company -24.98 %$ 13.049  millions
Pacific Biosciences Of California Inc -47.76 %$ 8.843  millions
Absci Corp -94.68 %$ 0.860  millions
The Pennant Group Inc -42.80 %$ 8.105  millions
23andme Holding Co -19.06 %$ 11.310  millions
Adma Biologics Inc -64.19 %$ 4.981  millions
Lifemd Inc -32.27 %$ 8.733  millions
Nurix Therapeutics Inc -31.39 %$ 8.401  millions
Taro Pharmaceutical Industries Ltd  48.39 %$ 17.871  millions
Adverum Biotechnologies Inc -93.16 %$ 0.808  millions
Ibio inc -50.66 %$ 5.738  millions
Artivion Inc -30.66 %$ 7.430  millions
Biolife Solutions Inc -38.56 %$ 6.381  millions
Inari Medical Inc -37.68 %$ 6.201  millions
Insmed Inc  34.52 %$ 13.288  millions
Cytek Biosciences Inc -51.08 %$ 4.827  millions
National Research Corporation  60.44 %$ 15.779  millions
Prestige Consumer Healthcare Inc -19.27 %$ 7.784  millions
Si bone inc -17.97 %$ 7.799  millions
Inspire Medical Systems inc   159.77 %$ 23.629  millions
Blueprint Medicines Corporation  80.09 %$ 16.062  millions
Generation Bio Co -15.95 %$ 7.397  millions
Veracyte inc   16.52 %$ 9.961  millions
Schrodinger Inc   67.24 %$ 13.403  millions
Arcutis Biotherapeutics Inc -94.54 %$ 0.428  millions
Amedisys Inc   76.20 %$ 12.713  millions
Olink Holding Ab publ   164.76 %$ 18.991  millions
Orasure Technologies Inc -14.35 %$ 5.802  millions
Barinthus Biotherapeutics Plc -11.81 %$ 5.413  millions
Castle Biosciences Inc   141.85 %$ 13.621  millions
Edgewise Therapeutics inc -83.36 %$ 0.923  millions
Healthcare Services Group Inc   3.76 %$ 5.406  millions
Bioventus Inc -8.46 %$ 4.568  millions
Springworks Therapeutics Inc -89.58 %$ 0.512  millions
Agios Pharmaceuticals Inc -79.53 %$ 0.999  millions

Other Companies within Healthcare Sector and their 2023 Capital Expenditures

Y/Y Annual Capital Expenditures Growth %

2023 Capital Expenditures
Novocure Limited  26.85 %$ 27.093  millions
Ionis Pharmaceuticals Inc  39.37 %$ 28.011  millions
Atricure Inc   148.79 %$ 41.998  millions
Neurocrine Biosciences Inc   71.52 %$ 28.300  millions
Xoma Corporation -99.89 %$ 0.017  millions
Myriad Genetics Inc   827.85 %$ 73.300  millions
Vericel Corporation  262.20 %$ 27.513  millions
Hims and Hers Health Inc   265.56 %$ 26.492  millions
Arcus Biosciences Inc   300.00 %$ 24.000  millions
Passage Bio inc -97.23 %$ 0.146  millions





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com